Structure Determination of Macrolactin Compounds with Antibacterial Activities Isolated from Bacillus polyfermenticus KJS-2 |
Kim, Dong-Hee
(Research and Development Center, Daewoo Pharmaceutical Co,. Ltd.)
Kang, Kyung-Ran (Research and Development Center, Daewoo Pharmaceutical Co,. Ltd.) Kim, Hyun-Woo (Technical Research Institute, Daesun Distilling Co., Ltd.) Yoon, Si-Yeol (Department of Pharmaceutical Engineering, Inje University) Kim, Chun-Gyu (Department of Pharmaceutical Engineering, Inje University) Yamaguchi, Tokutaro (Department of Pharmaceutical Engineering, Sun Moon University) Sohng, Jae-Kyung (Department of Pharmaceutical Engineering, Sun Moon University) Kang, Jae-Seon (Department of Pharmacy, Kyungsung University) |
1 | Arthur, M. and R. Quintiliani. 2001. Regulation of VanA‑and VanB‑type glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 45, 375-381. DOI |
2 | Auckland, C., L. Teare, F. Cooke, M. E. Kaufmann, M. Warner, G. Jones, K. Bamford, H. Ayles, and A. P. Johnson. 2002. Linezolid-resistant enterococci: report of the first isolates in the United Kingdom. J. Antimicrob. Chemother. 50, 743-746. DOI |
3 | Bagga, B. and J. L. Shenep. 2010. Management of infections caused by vancomycin-resistant Gram-positive bacteria. Pediatr. Infect. Dis. J. 29, 662-664. DOI |
4 | Choi, S. W., D. H. Bai, J. H. Yu, and C. S. Shin. 2003. Characteristics of the squalene synthase inhibitors produced by a Streptomyces species isolated from soils. Can. J. Microbiol. 49, 663-668. DOI |
5 | Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. J. Schwaber, A. W. Karchmer, and Y. Carmeli. 2003. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin. Infect. Dis. 36, 53-59. DOI |
6 | Fraser, T. G., C. Hansen, and J. K. Long. 2006. Newer antibiotics for serious gram-positive infections. Cle. Clin. J. Med. 73, 847-853. DOI |
7 | Goll, C., P. Balmer, F. Schwab, H. Rüden, and T. Eckmanns. 2007. Different trends of MRSA and VRE in a German Hospital, 1999-2005. Infection 35, 245-249. DOI |
8 | Gustafson, K., M. Roman, and W. Fenical. 1989. The macrolactins, a novel class of antiviral and cytotoxic macrolides from a deep-sea marine bacterium. J. Am. Chem. Soc. 111, 7519-7524. DOI |
9 | Yoo, J. S., C. J. Zheng, S. K. Lee, J. H. Kwak, and W. G. Kim. 2006. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorg. Med. Chem. Lett. 16, 4889-4892. DOI |
10 | Zheng, C. J., S. K. Lee, C. H. Lee, and W. G. Kim. 2007. Macrolactins O-R, glycosylated 24-membered lactones from Bacillus sp. AH159-1. J. Nat. Prod. 70, 1632-1635. DOI |
11 | Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40, 839-845. |
12 | Tsiodras, S., H. S. Gold, G. Sakoulas, G. M. Eliopoulos, C. Wennersten, L. Venkataraman, and R. C. Moellering. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358, 207-208. DOI |
13 | Norrby, S. R. 1995. Emerging antibiotic resistance in Gram positive bacteria: return to the pre-antibiotic era? HKMJ. 1, 129-135. |
14 | Presterl, E., W. Graninger, and A. Georgopoulos. 1993. The efficacy of teicoplanin in the treatment of endocarditis caused by Gram-positive bacteria. J. Antimicrob. Chemother. 31, 755-766. DOI |
15 | Rice, L. B. 2006. Antimicrobial resistance in gram-positive bacteria. Am. J. Infect. Control. 34, S11-S19. DOI |
16 | Romero-Tabarez, M., R. Jansen, M. Sylla, H. Lunsdorf, S. Haubler, D. A. Santosa, K. N. Timmis, and G. Molinari. 2006. 7-O-malonyl macrolactin A, a new macrolactin antibiotic from Bacillus subtilis active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, and a small-colony variant of Burkholderia cepacia. Antimicrob. Agents Chemother. 50, 1701-1709. DOI |
17 | Sohn, M. J., C. J. Zheng, and W. G. Kim. 2008. Macrolactin S, a new antibacterial agent with Fab G-inhibitory activity from Bacillus sp. AT28. J. Antibiot. 61, 687-691. DOI |
18 | Van der Auwera, P., M. Aoun, and F. Meunier. 1991. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts. Antimicrob. Agents Chemother. 35, 451-457. DOI ScienceOn |
19 | Von Baum, H., J. F. Ober, C. Wendt, R. P. Wenzel, and M. B. Edmond. 2005. Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population? Infection. 33, 320-326. DOI |
20 | Xue, C., L. Tian, M. Xu, Z. Deng, and W. Lin. 2008. A new 24-membered lactone and a new polyene -lactone from the marine bacterium Bacillus Marinus. J. Antibiot. 61, 668-674. DOI |
21 | Han, J. S., J. H. Cheng, T. M. Yoon, J. Song, A. Rajkarnikar, W. G. Kim, I. D. Yoo, and Y. Y. Yang. 2005. Biological control agent of common scab disease by antagonistic strain Bacillus sp. sunhua. J. Appl. Microbiol. 99, 213-221. DOI |
22 | Jaruchoktaweechai, C., K. Suwanborirux, S. Tanasupawatt, P. Kittakoop, and P. Menasveta. 2000. New macrolactins from a marine Bacillus sp. Sc026. J. Nat. Prod. 63, 984-986. DOI |
23 | Lee, S. J., J. Y. Cho, J. H. Moon, K. D. Park, Y. J. Lee, and K. H. Park. 2004. Isolation and characterization of antimicrobial substance macrolactin A produced from Bacillus amyloliquefaciens CHO104 isolated from soil. J. Microbiol. Biotechnol. 14, 525-531. 과학기술학회마을 |
24 | Kim, H. H., W. G. Kim, I. J. Ryoo, C. J. Kim, J. E. Suk, K. H. Han, S. Y. Hwang, and I. D. Yoo. 1997. Neuronal cell protection activity of macrolactin A produced by Actinomadura sp. J. Microbiol. Biotechnol. 7, 429-434. 과학기술학회마을 |
25 | Kim, K. M., M. J. Kim, D. H. Kim, Y. S. Park, and J. S. Kang. 2009. Characterization of Bacillus polyfermenticus KJS-2 as a Probiotic. J. Microbiol. Biotechnol. 19, 1013-1018. 과학기술학회마을 DOI |
26 | Lee, K. H., K. D. Jun, W. S. Kim, and H. D. Paik. 2001. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett. Appl. Microbiol. 32, 146-151. DOI |
27 | Lentino, J. R., M. Narita, and V. L. Yu. 2008. New antimicrobial agents as therapy for resistant gram-positive cocci. Eur. J. Clin. Microbiol. Infect. Dis. 27, 3-15. DOI |
28 | Nagao, T., M. Adachi, M. Sakai, M. Nishijima, and H. Sano. 2001. Novel macrolactins as antibiotic lactones from a marine bacterium. J. Antibiot. 54, 333-339. DOI ScienceOn |
29 | Neu, H. C. 1992. The crisis in antibiotic resistance. Science 254, 1064-1073. |